Tamarack Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Tamarack Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$897K	–	52
2022 Q3	$897K	Sell	50,000 -150,000	-75%	-$1.97M	0.53%	33
2022 Q2	$1.92M	Sell	200,000 -170,000	-46%	-$2.13M	1.11%	24
2022 Q1	$6.23M	Buy	370,000 +145,000	+64%	+$2.14M	2.95%	14
2021 Q4	$3.76M	Sell	225,000 -25,000	-10%	-$410K	1.55%	24
2021 Q3	$4.06M	Sell	250,000 -150,000	-38%	-$1.63M	1.28%	26
2021 Q2	$2.52M	Sell	400,000 -175,000	-30%	-$1.13M	0.71%	31
2021 Q1	$3.55M	Sell	575,000 -275,000	-32%	-$1.67M	0.73%	34
2020 Q4	$5.81M	Sell	850,000 -50,000	-6%	-$320K	1.21%	27
2020 Q3	$5.08M	Sell	900,000 -100,000	-10%	-$477K	1.56%	23
2020 Q2	$5.1M	Sell	1,000,000 -250,000	-20%	-$1.04M	1.42%	25
2020 Q1	$4.3M	Sell	1,250,000 -1,400,000	-53%	-$8.18M	1.63%	18
2019 Q4	$21.6M	Sell	2,650,000 -350,000	-12%	-$1.25M	4.93%	8
2019 Q3	$3.36M	Hold	3,000,000	–	–	0.88%	23
2019 Q2	$3.72M	Hold	3,000,000	–	–	1.13%	17
2019 Q1	$4.23M	Buy	3,000,000 +2,000,000	+200%	+$2.8M	1.68%	15
2018 Q4	$1.2M	Hold	1,000,000	–	–	0.49%	20
2018 Q3	$2.36M	Buy	1,000,000 +75,000	+8%	+$187K	0.67%	22
2018 Q2	$2.52M	Buy	925,000 +76,160	+9%	+$210K	0.85%	21
2018 Q1	$2.33M	Buy	848,840 +98,840	+13%	+$287K	1.11%	23
2017 Q4	$2.34M	Sell	750,000 -25,000	-3%	-$70.3K	1.28%	22
2017 Q3	$2.19M	Buy	775,000 +150,000	+24%	+$405K	1.34%	19
2017 Q2	$1.6M	Buy	625,000 +153,851	+33%	+$419K	0.93%	24
2017 Q1	$1.72M	Buy	+471,149	New	+$1.99M	1.08%	23

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tamarack Advisers's ISEE Position: Q4 2022 in Review

Tamarack Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 50,000 shares — an estimated $897K sold.

Tamarack Advisers first reported a position in ISEE in Q1 2017 and held it in 23 quarters. The position peaked at $21.6M in Q4 2019. 223 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Tamarack Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Tamarack Advisers sold 50,000 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $897K.
Tamarack Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q1 2017 and held it in 23 quarters.
Tamarack Advisers's IVERIC bio, Inc. Common Stock position peaked at $21.6M in Q4 2019.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Tamarack Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.